HEALTHJul 2 · 23:54 UTCKMGH DENVER7Jessica Porter

Judge suspends Colorado's price cap on prescription drug Embrel while lawsuit plays out

A Colorado judge suspended the state's price cap on the arthritis drug Enbrel, ruling it interferes with federal patent law. The cap, set at $31,000 annually, was blocked ahead of its 2027 implementation. Colorado's Prescription Drug Affordability Board, the first state entity to price-cap a drug, now faces legal uncertainty as Amgen challenges the policy.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Judge Daniel DomenicopersonAmgenorganizationEnbreltopicColorado Prescription Drug Affordability BoardorganizationColorado Consumer Health InitiativeorganizationAdam FoxpersonCosentyxtopicColorado Division of Insuranceorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 2 · 13:42 UTC
Judge temporarily blocks Colorado’s first-in-the-nation price cap on a prescription drug
HEALTHJun 5 · 09:30 UTC
A pharmaceutical company is trying to block Colorado’s first-in-the-nation drug price cap in court
HEALTHMay 18 · 22:08 UTC
STAT+: Maryland state affordability board places a price cap on Ozempic
HEALTHJun 11 · 20:49 UTC
WA’s controversial new drug pricing law upheld amid legal challenge
HEALTHJun 12 · 21:45 UTC
STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole